Literature DB >> 19370313

Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.

Chunquan Sheng1, Haitao Ji, Zhenyuan Miao, Xiaoyin Che, Jianzhong Yao, Wenya Wang, Guoqiang Dong, Wei Guo, Jiaguo Lü, Wannian Zhang.   

Abstract

Myristoyl-CoA:protein N-myristoyltransferase (NMT) is a cytosolic monomeric enzyme that catalyzes the transfer of the myristoyl group from myristoyl-CoA to the N-terminal glycine of a number of eukaryotic cellular and viral proteins. Recent experimental data suggest NMT from parasites could be a promising new target for the design of novel antiparasitic agents with new mode of action. However, the active site topology and inhibitor specificity of these enzymes remain unclear. In this study, three-dimensional models of NMT from Plasmodium falciparum (PfNMT), Leishmania major (LmNMT) and Trypanosoma brucei (TbNMT) were constructed on the basis of the crystal structures of fungal NMTs using homology modeling method. The models were further refined by energy minimization and molecular dynamics simulations. The active sites of PfNMT, LmNMT and TbNMT were characterized by multiple copy simultaneous search (MCSS). MCSS functional maps reveal that PfNMT, LmNMT and TbNMT share a similar active site topology, which is defined by two hydrophobic pockets, a hydrogen-bonding (HB) pocket, a negatively-charged HB pocket and a positively-charged HB pocket. Flexible docking approaches were then employed to dock known inhibitors into the active site of PfNMT. The binding mode, structure-activity relationships and selectivity of inhibitors were investigated in detail. From the results of molecular modeling, the active site architecture and certain key residues responsible for inhibitor binding were identified, which provided insights for the design of novel inhibitors of parasitic NMTs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370313     DOI: 10.1007/s10822-009-9267-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  39 in total

1.  Human N-myristoyltransferases form stable complexes with lentiviral nef and other viral and cellular substrate proteins.

Authors:  Brian T Hill; Jacek Skowronski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region.

Authors:  Jian Wu; Yong Tao; Meilan Zhang; Michael H Howard; Steven Gutteridge; Jianping Ding
Journal:  J Biol Chem       Date:  2007-05-18       Impact factor: 5.157

3.  Functionality maps of binding sites: a multiple copy simultaneous search method.

Authors:  A Miranker; M Karplus
Journal:  Proteins       Date:  1991

4.  Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs.

Authors:  R S Bhatnagar; K Fütterer; T A Farazi; S Korolev; C L Murray; E Jackson-Machelski; G W Gokel; J I Gordon; G Waksman
Journal:  Nat Struct Biol       Date:  1998-12

5.  Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites.

Authors:  Helen P Price; Malini R Menon; Chrysoula Panethymitaki; David Goulding; Paul G McKean; Deborah F Smith
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

6.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

7.  Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.

Authors:  J K Lodge; E Jackson-Machelski; D L Toffaletti; J R Perfect; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 8.  Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.

Authors:  Nafsika H Georgopapadakou
Journal:  Expert Opin Investig Drugs       Date:  2002-08       Impact factor: 6.206

9.  Genetic studies reveal that myristoylCoA:protein N-myristoyltransferase is an essential enzyme in Candida albicans.

Authors:  R A Weinberg; C A McWherter; S K Freeman; D C Wood; J I Gordon; S C Lee
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

10.  Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum.

Authors:  Paul W Bowyer; Ruwani S Gunaratne; Munira Grainger; Chrislaine Withers-Martinez; Sasala R Wickramsinghe; Edward W Tate; Robin J Leatherbarrow; Katherine A Brown; Anthony A Holder; Deborah F Smith
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

View more
  6 in total

1.  Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.

Authors:  Paulomi Paul; Abhishek Chowdhury; Anupam Das Talukdar; Manabendra Dutta Choudhury
Journal:  J Mol Model       Date:  2015-02-07       Impact factor: 1.810

Review 2.  Acylation in trypanosomatids: an essential process and potential drug target.

Authors:  Amanda M Goldston; Aabha I Sharma; Kimberly S Paul; David M Engman
Journal:  Trends Parasitol       Date:  2014-06-19

3.  Virtual screening to identify Leishmania braziliensis N-myristoyltransferase inhibitors: pharmacophore models, docking, and molecular dynamics.

Authors:  Juliana Cecília de Carvalho Gallo; Larissa de Mattos Oliveira; Janay Stefany Carneiro Araújo; Isis Bugia Santana; Manoelito Coelho Dos Santos Junior
Journal:  J Mol Model       Date:  2018-08-29       Impact factor: 1.810

Review 4.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

5.  N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.

Authors:  Julie A Frearson; Stephen Brand; Stuart P McElroy; Laura A T Cleghorn; Ondrej Smid; Laste Stojanovski; Helen P Price; M Lucia S Guther; Leah S Torrie; David A Robinson; Irene Hallyburton; Chidochangu P Mpamhanga; James A Brannigan; Anthony J Wilkinson; Michael Hodgkinson; Raymond Hui; Wei Qiu; Olawale G Raimi; Daan M F van Aalten; Ruth Brenk; Ian H Gilbert; Kevin D Read; Alan H Fairlamb; Michael A J Ferguson; Deborah F Smith; Paul G Wyatt
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

6.  Comparison of Newly Assembled Full Length HIV-1 Integrase With Prototype Foamy Virus Integrase: Structure-Function Prospective.

Authors:  Mohammad Reza Dayer
Journal:  Jundishapur J Microbiol       Date:  2016-02-15       Impact factor: 0.747

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.